Law360, New York (February 26, 2010, 2:04 PM EST) -- The Massachusetts Institute of Technology and the Max Planck Institute have filed a joint motion to dismiss the university from Max Planck's suit over RNA interference patents, following MIT's agreement to be bound by any declaratory judgment against its co-defendants.
The motion, filed Thursday in the U.S. District Court for the District of Massachusetts, stresses that the case remains pending against the other defendants, the University of Massachusetts and the Whitehead Institute for Biomedical Research.
According to the motion, MIT shall be bound by any equitable...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.